Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414

NCT06525168 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: DA414 Granules
DRUG: DA414 placebo

Sponsor

Chendu DIAO Nine Hong Pharmaceutical Factory